Ok. Gong
JPMorgan Chase & Co, Analysis Division
Okay. Thanks, everybody, for coming right now. My identify is Allen Gong, right here on the JPMorgan Medtech staff. I am actually excited to have the administration staff of iRhythm right here right now this morning. We’ll begin off with some ready remarks from CEO, Quentin Blackford, after which we’ll tag in Dan Wilson, CFO, for some Q&A after that. So Quentin, if you happen to may begin us off.
Quentin Blackford
President, CEO & Director
Terrific. Are you able to guys hear me okay? Thanks for having us, Allen. We admire the chance to be right here. We’re excited to be right here, coming off of an unbelievable 2025 for iRhythm, and we’re wanting ahead to an much more thrilling 2026. As we glance forward, only a fast reminder, I might be utilizing forward-looking statements through the course of this morning’s presentation. I might refer you to our firm web site, firm filings for any additional info that you just is likely to be in search of there.
When a sign modifications all the pieces, after we speak about indicators in arrhythmias, we’re not speaking about simply anybody specific factor, sign present up in a wide range of other ways. And it is the complexity of that, that creates the problem for gamers on this house, for us, it additionally turns into the chance. We take into consideration how these indicators present up in observe every day, typically it is a story like Carissa, who finds herself within the ER, coping with extreme well being points, solely to have an EKG carried out and instructed her that all the pieces is completely wonderful. She is shipped dwelling, no points. She finds
